Dr. Reddy’s Laboratories

Dr. Reddy's Laboratories was founded in 1984 by Dr. K. Anji Reddy, a visionary in the pharmaceutical industry. The company began its journey in Hyderabad, India, with a focus on producing affordable and high-quality generic medications. Dr. Reddy's Laboratories quickly established itself as a key player in the Indian pharmaceutical market.

In 1986, the company made a significant move by becoming the first Indian company to export active pharmaceutical ingredients (APIs) to Europe. This marked the beginning of its international expansion. By the early 1990s, Dr. Reddy's had entered the U.S. market, further solidifying its global presence.

A pivotal moment in the company's history came in 2001 when Dr. Reddy's Laboratories became the first Indian pharmaceutical company to be listed on the New York Stock Exchange (NYSE). This milestone not only highlighted the company's growth but also its commitment to transparency and global standards.

Throughout the years, Dr. Reddy's Laboratories has continued to innovate and expand its product offerings. The company has invested heavily in research and development, leading to the creation of new and improved medications. Its dedication to providing affordable healthcare solutions has remained a core principle.

Today, Dr. Reddy's Laboratories is recognized as a global pharmaceutical leader, with a presence in over 150 countries. The company's journey from a small startup in Hyderabad to a multinational corporation is a testament to its resilience and commitment to improving global health.